These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 21769078)
21. Radioembolization for hepatocellular carcinoma. Sangro B; IƱarrairaegui M; Bilbao JI J Hepatol; 2012 Feb; 56(2):464-73. PubMed ID: 21816126 [TBL] [Abstract][Full Text] [Related]
22. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma. Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647 [TBL] [Abstract][Full Text] [Related]
23. Transarterial radioembolization with Yttrium-90 for regional management of hepatocellular cancer: the early results of a nontransplant center. Holt A; Wagman LD; Senthil M; McKenzie S; Marx H; Chen YJ; Vora N; Kim J Am Surg; 2010 Oct; 76(10):1079-83. PubMed ID: 21105614 [TBL] [Abstract][Full Text] [Related]
24. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres. Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957 [TBL] [Abstract][Full Text] [Related]
25. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867 [TBL] [Abstract][Full Text] [Related]
26. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639 [TBL] [Abstract][Full Text] [Related]
27. Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries. Lauenstein TC; Heusner TA; Hamami M; Ertle J; Schlaak JF; Gerken G; Bockisch A; Antoch G Rofo; 2011 Nov; 183(11):1058-64. PubMed ID: 21959887 [TBL] [Abstract][Full Text] [Related]
32. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma. Memon K; Lewandowski RJ; Riaz A; Salem R Recent Results Cancer Res; 2013; 190():207-24. PubMed ID: 22941023 [TBL] [Abstract][Full Text] [Related]
33. The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization. Wallace MC; Samuelson S; Khoo T; Ooi J; Tibballs J; Ferguson J; Preen DB; Knuiman M; Garas G; MacQuillan G; Adams LA; Jeffrey GP J Gastroenterol Hepatol; 2020 Nov; 35(11):1945-1952. PubMed ID: 32036614 [TBL] [Abstract][Full Text] [Related]
34. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how? Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960 [TBL] [Abstract][Full Text] [Related]
35. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954 [TBL] [Abstract][Full Text] [Related]
36. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187 [TBL] [Abstract][Full Text] [Related]
37. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Sangro B; Carpanese L; Cianni R; Golfieri R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Van Buskirk M; Bilbao JI; Ettorre GM; Salvatori R; Giampalma E; Geatti O; Wilhelm K; Hoffmann RT; Izzo F; IƱarrairaegui M; Maini CL; Urigo C; Cappelli A; Vit A; Ahmadzadehfar H; Jakobs TF; Lastoria S; Hepatology; 2011 Sep; 54(3):868-78. PubMed ID: 21618574 [TBL] [Abstract][Full Text] [Related]
38. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres. Li MD; Chu KF; DePietro A; Wu V; Wehrenberg-Klee E; Zurkiya O; Liu RW; Ganguli S J Vasc Interv Radiol; 2019 Mar; 30(3):314-319. PubMed ID: 30819470 [TBL] [Abstract][Full Text] [Related]
39. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres. Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356 [TBL] [Abstract][Full Text] [Related]
40. Thrombocytopenia following 90Yttrium glass microsphere liver radioembolization. Gundavaram P; Gaba RC South Med J; 2011 Apr; 104(4):286. PubMed ID: 21606701 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]